Your browser doesn't support javascript.
loading
High-dimensional single-cell analysis of human natural killer cell heterogeneity.
Rebuffet, Lucas; Melsen, Janine E; Escalière, Bertrand; Basurto-Lozada, Daniela; Bhandoola, Avinash; Björkström, Niklas K; Bryceson, Yenan T; Castriconi, Roberta; Cichocki, Frank; Colonna, Marco; Davis, Daniel M; Diefenbach, Andreas; Ding, Yi; Haniffa, Muzlifah; Horowitz, Amir; Lanier, Lewis L; Malmberg, Karl-Johan; Miller, Jeffrey S; Moretta, Lorenzo; Narni-Mancinelli, Emilie; O'Neill, Luke A J; Romagnani, Chiara; Ryan, Dylan G; Sivori, Simona; Sun, Dan; Vagne, Constance; Vivier, Eric.
Afiliación
  • Rebuffet L; Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
  • Melsen JE; Leiden University Medical Center, Willem-Alexander Children's Hospital, Laboratory for Pediatric Immunology, Leiden, the Netherlands.
  • Escalière B; Leiden University Medical Center, Department of Immunology, Leiden, the Netherlands.
  • Basurto-Lozada D; Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
  • Bhandoola A; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Björkström NK; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Bryceson YT; T Cell Biology and Development Unit, Laboratory of Genome Integrity, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Castriconi R; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Cichocki F; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Colonna M; Division of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Davis DM; Sweden Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Diefenbach A; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
  • Ding Y; Laboratory of Clinical and Experimental Immunology, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Haniffa M; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Horowitz A; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Lanier LL; Department of Life Sciences, Imperial College London, Sir Alexander Fleming Building, South Kensington, London, UK.
  • Malmberg KJ; Laboratory of Innate Immunity, Institute of Microbiology, Infectious Diseases and Immunology (I-MIDI), Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Miller JS; Mucosal and Developmental Immunology, Deutsches Rheuma-Forschungszentrum (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.
  • Moretta L; T Cell Biology and Development Unit, Laboratory of Genome Integrity, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Narni-Mancinelli E; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • O'Neill LAJ; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Romagnani C; Department of Dermatology and NIHR Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Ryan DG; Department of Immunology & Immunotherapy, The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sivori S; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sun D; Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, USA.
  • Vagne C; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Vivier E; Precision Immunotherapy Alliance, The University of Oslo, Oslo, Norway.
Nat Immunol ; 2024 Jul 02.
Article en En | MEDLINE | ID: mdl-38956378
ABSTRACT
Natural killer (NK) cells are innate lymphoid cells (ILCs) contributing to immune responses to microbes and tumors. Historically, their classification hinged on a limited array of surface protein markers. Here, we used single-cell RNA sequencing (scRNA-seq) and cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) to dissect the heterogeneity of NK cells. We identified three prominent NK cell subsets in healthy human blood NK1, NK2 and NK3, further differentiated into six distinct subgroups. Our findings delineate the molecular characteristics, key transcription factors, biological functions, metabolic traits and cytokine responses of each subgroup. These data also suggest two separate ontogenetic origins for NK cells, leading to divergent transcriptional trajectories. Furthermore, we analyzed the distribution of NK cell subsets in the lung, tonsils and intraepithelial lymphocytes isolated from healthy individuals and in 22 tumor types. This standardized terminology aims at fostering clarity and consistency in future research, thereby improving cross-study comparisons.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Francia
...